Global Gastroparesis Treatment Market Overview:
Global Gastroparesis Treatment Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2024 as the base year.
Global Gastroparesis Treatment Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Gastroparesis Treatment involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Gastroparesis Treatment Market:
The Gastroparesis Treatment Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Gastroparesis Treatment Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Gastroparesis Treatment Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Gastroparesis Treatment market has been segmented into:
Prokinetic Agents
Antiemetic Drugs
Proton Pump Inhibitors
Others
By Application, Gastroparesis Treatment market has been segmented into:
Diabetes Gastroparesis
Idiopathic Gastroparesis
Post-surgical Gastroparesis
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Gastroparesis Treatment market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Gastroparesis Treatment market.
Top Key Players Covered in Gastroparesis Treatment market are:
Evoke Pharma
Inc.
Processa Pharmaceuticals
Inc.
Neurogastrx
Inc.
Vanda Pharmaceuticals Inc.
ANI Pharmaceuticals
Inc.
Takeda Pharmaceutical Company Limited
GlaxoSmithKline plc
Otsuka Holdings Co. Ltd
CinDome Pharma
Inc.
PTC Therapeutics
Pfizer
Inc.
Teva Pharmaceutical Industries Ltd.
Atlantic Healthcare
Salix Pharmaceuticals
Rhythm Pharmaceuticals
Inc.
Ironwood Pharmaceuticals
Inc.
Medtronic plc
Bausch Health Companies Inc.
Sanofi S.A.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Gastroparesis Treatment Market by Type
4.1 Gastroparesis Treatment Market Snapshot and Growth Engine
4.2 Gastroparesis Treatment Market Overview
4.3 Prokinetic Agents
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Prokinetic Agents: Geographic Segmentation Analysis
4.4 Antiemetic Drugs
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Antiemetic Drugs: Geographic Segmentation Analysis
4.5 Proton Pump Inhibitors
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Proton Pump Inhibitors: Geographic Segmentation Analysis
4.6 Others
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Others: Geographic Segmentation Analysis
Chapter 5: Gastroparesis Treatment Market by Application
5.1 Gastroparesis Treatment Market Snapshot and Growth Engine
5.2 Gastroparesis Treatment Market Overview
5.3 Diabetes Gastroparesis
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Diabetes Gastroparesis: Geographic Segmentation Analysis
5.4 Idiopathic Gastroparesis
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Idiopathic Gastroparesis: Geographic Segmentation Analysis
5.5 Post-surgical Gastroparesis
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Post-surgical Gastroparesis: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Gastroparesis Treatment Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 EVOKE PHARMA
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 INC.
6.4 PROCESSA PHARMACEUTICALS
6.5 INC.
6.6 NEUROGASTRX
6.7 INC.
6.8 VANDA PHARMACEUTICALS INC.
6.9 ANI PHARMACEUTICALS
6.10 INC.
6.11 TAKEDA PHARMACEUTICAL COMPANY LIMITED
6.12 GLAXOSMITHKLINE PLC
6.13 OTSUKA HOLDINGS CO.
6.14 LTD.
6.15 CINDOME PHARMA
6.16 INC.
6.17 PTC THERAPEUTICS
6.18 PFIZER
6.19 INC.
6.20 TEVA PHARMACEUTICAL INDUSTRIES LTD.
6.21 ATLANTIC HEALTHCARE
6.22 SALIX PHARMACEUTICALS
6.23 RHYTHM PHARMACEUTICALS
6.24 INC.
6.25 IRONWOOD PHARMACEUTICALS
6.26 INC.
6.27 MEDTRONIC PLC
6.28 BAUSCH HEALTH COMPANIES INC.
6.29 SANOFI S.A.
Chapter 7: Global Gastroparesis Treatment Market By Region
7.1 Overview
7.2. North America Gastroparesis Treatment Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Prokinetic Agents
7.2.4.2 Antiemetic Drugs
7.2.4.3 Proton Pump Inhibitors
7.2.4.4 Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Diabetes Gastroparesis
7.2.5.2 Idiopathic Gastroparesis
7.2.5.3 Post-surgical Gastroparesis
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Gastroparesis Treatment Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Prokinetic Agents
7.3.4.2 Antiemetic Drugs
7.3.4.3 Proton Pump Inhibitors
7.3.4.4 Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Diabetes Gastroparesis
7.3.5.2 Idiopathic Gastroparesis
7.3.5.3 Post-surgical Gastroparesis
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Gastroparesis Treatment Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Prokinetic Agents
7.4.4.2 Antiemetic Drugs
7.4.4.3 Proton Pump Inhibitors
7.4.4.4 Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Diabetes Gastroparesis
7.4.5.2 Idiopathic Gastroparesis
7.4.5.3 Post-surgical Gastroparesis
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Gastroparesis Treatment Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Prokinetic Agents
7.5.4.2 Antiemetic Drugs
7.5.4.3 Proton Pump Inhibitors
7.5.4.4 Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Diabetes Gastroparesis
7.5.5.2 Idiopathic Gastroparesis
7.5.5.3 Post-surgical Gastroparesis
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Gastroparesis Treatment Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Prokinetic Agents
7.6.4.2 Antiemetic Drugs
7.6.4.3 Proton Pump Inhibitors
7.6.4.4 Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Diabetes Gastroparesis
7.6.5.2 Idiopathic Gastroparesis
7.6.5.3 Post-surgical Gastroparesis
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Gastroparesis Treatment Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Prokinetic Agents
7.7.4.2 Antiemetic Drugs
7.7.4.3 Proton Pump Inhibitors
7.7.4.4 Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Diabetes Gastroparesis
7.7.5.2 Idiopathic Gastroparesis
7.7.5.3 Post-surgical Gastroparesis
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Gastroparesis Treatment Scope:
|
Report Data
|
Gastroparesis Treatment Market
|
|
Gastroparesis Treatment Market Size in 2025
|
USD XX million
|
|
Gastroparesis Treatment CAGR 2025 - 2032
|
XX%
|
|
Gastroparesis Treatment Base Year
|
2024
|
|
Gastroparesis Treatment Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Evoke Pharma, Inc., Processa Pharmaceuticals, Inc., Neurogastrx, Inc., Vanda Pharmaceuticals Inc., ANI Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Otsuka Holdings Co., Ltd., CinDome Pharma, Inc., PTC Therapeutics, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Atlantic Healthcare, Salix Pharmaceuticals, Rhythm Pharmaceuticals, Inc., Ironwood Pharmaceuticals, Inc., Medtronic plc, Bausch Health Companies Inc., Sanofi S.A..
|
|
Key Segments
|
By Type
Prokinetic Agents
Antiemetic Drugs
Proton Pump Inhibitors
Others
By Applications
Diabetes Gastroparesis
Idiopathic Gastroparesis
Post-surgical Gastroparesis
|
